DelMar Pharmaceuticals Announces Abstract Presentations for the American Association Cancer Research (AACR) Annual Meeting in April 2016 March 24, 2016 • 8:00 AM EDT
DelMar Pharmaceuticals Announces Second Quarter Fiscal Year 2016 Financial Results and Corporate Update February 16, 2016 • 7:35 AM EST
DelMar Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference on February 8, 2016 February 4, 2016 • 7:35 AM EST
DelMar Pharmaceuticals to Collaborate with MD Anderson Cancer Center on Development of DelMar's VAL-083 in Brain Cancer January 13, 2016 • 8:05 AM EST
DelMar Pharmaceuticals to Present at the Biotech Showcase™ 2016 on January 12, 2016 January 5, 2016 • 7:00 AM EST
DelMar Pharmaceuticals Updates VAL-083 Clinical Trial in Refractory Glioblastoma Multiforme at Society for Neuro-Oncology Annual Meeting November 23, 2015 • 8:05 AM EST
DelMar Pharmaceuticals to Present at the 8th Annual LD Micro Main Event on December 2, 2015 November 19, 2015 • 8:05 AM EST
DelMar Pharmaceuticals Reports First Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update November 17, 2015 • 8:05 AM EST
DelMar Pharmaceuticals Presents Data Summarizing the Potential of VAL-083 as a New Treatment Option for Resistant Cancers November 13, 2015 • 7:35 AM EST